Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

June 3, 2024

Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.

Buyers
Formosa Laboratories, Inc.
Targets
SynChem, Inc.
Industry
Pharmaceuticals
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.